BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 29624247)

  • 1. Heat and α1-adrenergic responsiveness in human skeletal muscle feed arteries: the role of nitric oxide.
    Ives SJ; Andtbacka RH; Kwon SH; Shiu YT; Ruan T; Noyes RD; Zhang QJ; Symons JD; Richardson RS
    J Appl Physiol (1985); 2012 Dec; 113(11):1690-8. PubMed ID: 23042905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up Regulation of cystathione γ lyase and Hydrogen Sulphide in the Myocardium Inhibits the Progression of Isoproterenol-Caffeine Induced Left Ventricular Hypertrophy in Wistar Kyoto Rats.
    Ahmad A; Sattar MA; Rathore HA; Abdulla MH; Khan SA; Azam M; Abdullah NA; Johns EJ
    PLoS One; 2016; 11(3):e0150137. PubMed ID: 26963622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
    Kovács ZZA; Szűcs G; Freiwan M; Kovács MG; Márványkövi FM; Dinh H; Siska A; Farkas K; Kovács F; Kriston A; Horváth P; Kővári B; Cserni BG; Cserni G; Földesi I; Csont T; Sárközy M
    Sci Rep; 2021 Sep; 11(1):17495. PubMed ID: 34471171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nitric Oxide in the Cardiovascular and Renal Systems.
    Ahmad A; Dempsey SK; Daneva Z; Azam M; Li N; Li PL; Ritter JK
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional contribution of α1D-adrenoceptors in the renal vasculature of left ventricular hypertrophy induced with isoprenaline and caffeine in Wistar-Kyoto rats.
    Ahmad A; Sattar MA; Rathore HA; Abdulla MH; Khan SA; Abdullah NA; Kaur G; Johns EJ
    Can J Physiol Pharmacol; 2014 Dec; 92(12):1029-35. PubMed ID: 25403946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between nitric oxide and renal α1-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats.
    Ahmad A; Sattar MA; Azam M; Khan SA; Bhatt O; Johns EJ
    PLoS One; 2018; 13(2):e0189386. PubMed ID: 29447158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystathione gamma lyase/Hydrogen Sulphide Pathway Up Regulation Enhances the Responsiveness of α1A and α1B-Adrenoreceptors in the Kidney of Rats with Left Ventricular Hypertrophy.
    Ahmad A; Sattar MA; Azam M; Abdulla MH; Khan SA; Hashmi F; Abdullah NA; Johns EJ
    PLoS One; 2016; 11(5):e0154995. PubMed ID: 27191852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of endothelial nitric oxide synthase in the myocardium ameliorates the progression of left ventricular hypertrophy in L-arginine treated Wistar-Kyoto rats.
    Ahmad A; Sattar MA; Rathore HA; Abdulla MH; Khan SA; Abdullah NA; Johns EJ
    J Physiol Pharmacol; 2016 Feb; 67(1):31-44. PubMed ID: 27010893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPACT OF ISOPRENALINE AND CAFFEINE ON DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY AND RENAL HEMODYNAMIC IN WISTAR KYOTO RATS.
    Ahmad A; Sattar MZ; Rathore HA; Khan SA; Lazhari MA; Hashmi F; Abdullah NA; Johns EJ
    Acta Pol Pharm; 2015; 72(5):1015-26. PubMed ID: 26665409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INCREASED OXIDATIVE STRESS AND DOWN REGULATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) IN THE KIDNEY ATTEN- UATE THE RESPONSIVENESS OF (XlB ADRENERGIC RECEPTORS IN THE KIDNEY OF RATS WITH LEFT VENTRICULAR HYPERTROPHY.
    Ahmad A; Sattar M; Khan SA; Abdullah NA; Johns EJ; Afzal S
    Acta Pol Pharm; 2017 Mar; 74(2):413-423. PubMed ID: 29624247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy.
    Raij L
    Hypertension; 1998 Jan; 31(1 Pt 2):189-93. PubMed ID: 9453301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide.
    Garcia JA; Incerpi EK
    Arq Bras Cardiol; 2008 Jun; 90(6):409-16. PubMed ID: 18592095
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.